KR960010649A - 이중환상 옥사졸 및 티아졸 치환된 에테르 - Google Patents
이중환상 옥사졸 및 티아졸 치환된 에테르 Download PDFInfo
- Publication number
- KR960010649A KR960010649A KR1019950029478A KR19950029478A KR960010649A KR 960010649 A KR960010649 A KR 960010649A KR 1019950029478 A KR1019950029478 A KR 1019950029478A KR 19950029478 A KR19950029478 A KR 19950029478A KR 960010649 A KR960010649 A KR 960010649A
- Authority
- KR
- South Korea
- Prior art keywords
- hydrogen
- compound
- appropriate
- halo
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
본 발명은 유리 형태 또는 적절한 경우 염 형태의 하기 일반식 (Ⅰ)의 옥사졸 및 티아졸 화합물에 관한 것이다.
상기 식에서, 치환기는 다양한 의미를 갖는다.
예컨대 커플링 또는 가수분해레 의해 이들을 제조할 수 있다.
상기 화합물은 약제, 특히 당뇨병 치료시 혈당저하제로서 사용될 수 있다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (5)
- 유리 형태 또는 적절한 경우 염 형태의 하기 일반식(Ⅰ)의 화합물:상기 식에서, X및 Y는 각각 독립적으로 산소 또는 황이고;Z는 -CR1R2-또는 -CR1R2CH2-이고;R1및 R2는 각각 독립적이고 수소 또는 저급 알킬이고;R3은 독립적으로 할로, 저급 알킬, 저급 알콕시 또는 트리 플루오로메틸에 의해 임의적으로 단일-또는 이중치환된 페닐;비페닐;페녹시페닐;나프틸;9,10-디하이드 오페난트릴; 또는 피리딜이고;R4및 R5는 각각 독립적으로 수소, 할로, 저급 알킬, 저급 알콕시, 트리플루오로메탈 또는 -COOR6이며;R6수소, 저급 알킬 또는 트리(저급)알킬실릴(저급)알킬이다.
- 제1항에 있어서, X및 Y가 제1항에 정의된 바와 같고; Z가 -CH2-, -C(CH3)2-또는 -CH2CH2-이고;R3이 독립적으로 할로, 메톡시 또는 트리플루오로메틸에 의해 임의적으로 단일-또는 이중치환된 페닐;4-페녹시페닐;나프틸;9,10-디하이드로페난트릴; 또는 피리딜이며;R4가 수소; 할로;메톡시;트리플루오로메틸; 또는 COOR6이며; R6이 수소, 메틸 또는(2-트리메틸실릴)에틸이고; R5가 수소 또는 할로인 유리 형태 또는 적절한 경우 염 형태의 일반식(Ⅰ)의 화합물.
- 유리 형태 또는 적절한 경우 염 현태의 (-)-트랜스-2S-[(4-클로로페녹시)메틸]-7a-(3,4-디클로로페닐)-2,3,7,7a-테트라하이드로피롤로[2,1-b]옥사졸-5(6H)-온.
- a)R6이 수소가 아닌 일반식(Ⅰ)의 화합물을 제조하는 경우, 하기 일반식(Ⅱ)의 화합물을 하기 일반식(Ⅲ)의 화합물과 반응시키거나, 또는 b)R6이 수소인 일반식(Ⅰ)의 화합물을 제조하는 경우, R6이 저급 알킬 또는 트리(저급)알킬실릴(저급)알킬인 일반식(Ⅰ)의 화합물을 가수분해시키고 생성된 유리 형태 또는 적절한 경우 염 형태의 일반식(Ⅰ)의 화합물을 회수하는 것을 포함하는 제1항에 따른 화합물의 제조방법:상기식에서, R3, R4, R5, X및 Z는 제1항에 정의된 바와 같고, R7은수소 또는 아민 보호기이다.
- 약학적으로 허용가능한 담체 또는 희석제 하나 이상과 함께 유리 형태 또는 적절한 경우 약리학적으로 허용가능한 염 형태의 제1항 내지 제3항 중 어느 한 항에 따른 화합물을 포함하는 약학 조성물.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30524994A | 1994-09-13 | 1994-09-13 | |
US08/305,249 | 1994-09-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR960010649A true KR960010649A (ko) | 1996-04-20 |
Family
ID=23180015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950029478A KR960010649A (ko) | 1994-09-13 | 1995-09-11 | 이중환상 옥사졸 및 티아졸 치환된 에테르 |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0702015B1 (ko) |
JP (1) | JPH08109183A (ko) |
KR (1) | KR960010649A (ko) |
CN (1) | CN1130186A (ko) |
AT (1) | ATE158585T1 (ko) |
AU (1) | AU3055295A (ko) |
BR (1) | BR9504004A (ko) |
CA (1) | CA2157950A1 (ko) |
CO (1) | CO4410332A1 (ko) |
CZ (1) | CZ229595A3 (ko) |
DE (1) | DE69500758T2 (ko) |
DK (1) | DK0702015T3 (ko) |
ES (1) | ES2108550T3 (ko) |
FI (1) | FI954257A (ko) |
GR (1) | GR3025405T3 (ko) |
HU (1) | HUT73432A (ko) |
IL (1) | IL115235A0 (ko) |
MY (1) | MY132008A (ko) |
NO (1) | NO953569L (ko) |
NZ (1) | NZ272976A (ko) |
PE (1) | PE50296A1 (ko) |
PL (1) | PL310372A1 (ko) |
SI (1) | SI0702015T1 (ko) |
SK (1) | SK111195A3 (ko) |
TR (1) | TR199501115A2 (ko) |
ZA (1) | ZA957699B (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002083863A2 (en) | 2001-04-17 | 2002-10-24 | Sepracor, Inc. | Thiazole and other heterocyclic ligands and use thereof |
DE10333935A1 (de) * | 2003-07-25 | 2005-02-24 | Aventis Pharma Deutschland Gmbh | Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
FR2858321B1 (fr) * | 2003-07-28 | 2006-01-20 | Servier Lab | Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1249992A (en) * | 1983-11-10 | 1989-02-14 | Marcel Muller | Oxazolidines |
ES2139633T3 (es) * | 1992-08-31 | 2000-02-16 | Sankyo Co | Derivados de oxazolidina con propiedades anti-diabetica y anti-obesidad, su preparacion y su utilizacion terapeutica. |
US5321036A (en) * | 1993-02-10 | 1994-06-14 | Bristol-Myers Squibb Company | Thiazole and oxazole-based β3 adrenergic receptor agonists |
US5521202A (en) * | 1993-04-07 | 1996-05-28 | Taiho Pharmaceutical Co., Ltd. | Thiazolidine derivatives and pharmaceutical compositions containing the same |
-
1995
- 1995-09-06 SK SK1111-95A patent/SK111195A3/sk unknown
- 1995-09-07 CZ CZ952295A patent/CZ229595A3/cs unknown
- 1995-09-11 DK DK95810561.1T patent/DK0702015T3/da active
- 1995-09-11 KR KR1019950029478A patent/KR960010649A/ko not_active Application Discontinuation
- 1995-09-11 PL PL95310372A patent/PL310372A1/xx unknown
- 1995-09-11 SI SI9530038T patent/SI0702015T1/xx unknown
- 1995-09-11 JP JP7257240A patent/JPH08109183A/ja active Pending
- 1995-09-11 CA CA002157950A patent/CA2157950A1/en not_active Abandoned
- 1995-09-11 AU AU30552/95A patent/AU3055295A/en not_active Abandoned
- 1995-09-11 AT AT95810561T patent/ATE158585T1/de not_active IP Right Cessation
- 1995-09-11 NO NO953569A patent/NO953569L/no unknown
- 1995-09-11 IL IL11523595A patent/IL115235A0/xx unknown
- 1995-09-11 NZ NZ272976A patent/NZ272976A/en unknown
- 1995-09-11 FI FI954257A patent/FI954257A/fi not_active Application Discontinuation
- 1995-09-11 DE DE69500758T patent/DE69500758T2/de not_active Expired - Fee Related
- 1995-09-11 PE PE1995278667A patent/PE50296A1/es not_active Application Discontinuation
- 1995-09-11 ES ES95810561T patent/ES2108550T3/es not_active Expired - Lifetime
- 1995-09-11 MY MYPI95002690A patent/MY132008A/en unknown
- 1995-09-11 EP EP95810561A patent/EP0702015B1/en not_active Expired - Lifetime
- 1995-09-12 CO CO95041744A patent/CO4410332A1/es unknown
- 1995-09-12 TR TR95/01115A patent/TR199501115A2/xx unknown
- 1995-09-12 BR BR9504004A patent/BR9504004A/pt not_active Application Discontinuation
- 1995-09-12 HU HU9502663A patent/HUT73432A/hu unknown
- 1995-09-12 CN CN95115726A patent/CN1130186A/zh active Pending
- 1995-09-13 ZA ZA957699A patent/ZA957699B/xx unknown
-
1997
- 1997-11-19 GR GR970403050T patent/GR3025405T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
MY132008A (en) | 2007-09-28 |
CA2157950A1 (en) | 1996-03-14 |
PE50296A1 (es) | 1996-12-05 |
ZA957699B (en) | 1997-03-13 |
AU3055295A (en) | 1996-03-28 |
NZ272976A (en) | 1996-09-25 |
FI954257A0 (fi) | 1995-09-11 |
DE69500758T2 (de) | 1998-02-26 |
CZ229595A3 (en) | 1996-04-17 |
BR9504004A (pt) | 1996-09-24 |
SI0702015T1 (en) | 1998-02-28 |
SK111195A3 (en) | 1997-06-04 |
FI954257A (fi) | 1996-03-14 |
IL115235A0 (en) | 1995-12-31 |
TR199501115A2 (tr) | 1996-06-21 |
CN1130186A (zh) | 1996-09-04 |
HUT73432A (en) | 1996-07-29 |
GR3025405T3 (en) | 1998-02-27 |
JPH08109183A (ja) | 1996-04-30 |
ATE158585T1 (de) | 1997-10-15 |
CO4410332A1 (es) | 1997-01-09 |
EP0702015B1 (en) | 1997-09-24 |
DK0702015T3 (da) | 1998-01-12 |
NO953569L (no) | 1996-03-14 |
EP0702015A1 (en) | 1996-03-20 |
PL310372A1 (en) | 1996-03-18 |
NO953569D0 (no) | 1995-09-11 |
DE69500758D1 (de) | 1997-10-30 |
ES2108550T3 (es) | 1997-12-16 |
HU9502663D0 (en) | 1995-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI893467A0 (fi) | Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi | |
NZ508066A (en) | Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity | |
GB8919434D0 (en) | Novel compounds | |
KR910011809A (ko) | 2-치환된 페닐-2-옥사졸린 또는 티아졸린 유도체, 그의 제조방법 및 그를 함유하는 살충제 및 살비제 | |
CA2036876A1 (fr) | Derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
RU92016545A (ru) | Гетероциклические соединения, способ их получения и фармацевтическая композиция | |
NO179204C (no) | Analogifremgangsmåte for fremstilling av bifenylguanidinderivater | |
DK0615549T3 (da) | Fremgangsmåde til fremstilling af farmaceutisk aktive thiazolidin- eller oxazolidinforbindelser med en gærreduktase | |
DE69607272D1 (de) | Herstellung von substituierten Thiazolen | |
HUT50337A (en) | Process for producing benzoxazine derivatives and pharmaceutical compositions comprising the compounds | |
AU566770B2 (en) | Benyoylurea compositions | |
KR960010649A (ko) | 이중환상 옥사졸 및 티아졸 치환된 에테르 | |
DE3174132D1 (en) | New ethenylimidazole derivatives, processes for their preparation and pharmaceutical compositions containing them; intermediates, useful in their preparation and a process for the preparation thereof | |
KR880007490A (ko) | 치환된 아미노프로피온아미드, 이의 제조방법, 이를 함유하는 약제, 이의 용도 및 이의 제조시에 생성된 중간체 | |
EG19557A (en) | A process for the preparation of pharmaceutical preparation | |
ATE19879T1 (de) | Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
SE9402596L (sv) | Karboximetylidencykloheptimidazolderivat, förfarande för deras framställning och terapeutiska medel innehållande dessa föreningar | |
ATE96803T1 (de) | Indolo(3,2,1-de>(1,4>-oxazino(2,3,4ij>(1,5>naphthyridinderivate, verfahren zu ihrer herstellung und zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende zubereitungen. | |
KR910021373A (ko) | 1-페녹시카보닐-2-피롤리디논 유도체 및 향정신성 약제 | |
TH14462EX (th) | สารประกอบซึ่งเป็นประโยชน์ในฐานะเป็นสารลดน้ำตาลในโลหิตและสำหรับรักษาโรคอัลส์ไฮเมอร์ | |
DE3784883T2 (de) | Fluor enthaltende makrolid-verbindungen, pharmazeutische zusammensetzungen, welche diese enthalten und ihre verwendung fuer die herstellung von arzneimitteln. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |